Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
Public ClinicalTrials.gov record NCT05612867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
High Dose Intravenous Versus Low Dose Oral Vitamin C in Burn Care: Potential Protective Effects in the Severely Burned: A Retrospective Cohort Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Burn injury is marked by a large release of inflammatory mediators which disrupt the normal capillary barrier and cause a rapid shift of intravascular fluid into interstitial spaces, ultimately leading to shock and death. As such, adequate fluid management and resuscitation is critical for burn patients to prevent further cellular injury. Technologies and medical options such as cardiac output monitoring along with early tube feeding and vitamin C administration have developed slowly over the years. Effective management of the Systemic Inflammatory Response Syndrome response and metabolic derangement is crucial for the survival of burn patients. In particular, vitamin C administration has shown to significantly decreases early post-burn lipid peroxidation, reduce microvascular leak of fluid by preventing endothelial dysfunction, and decreases edema formation in burned tissue. Vitamin C is a cheap and widely available antioxidant which has been shown to significantly effective in positively impacting clinical outcomes in burn resuscitation. We aim to evaluate the efficacy of vitamin C in burns greater than 20% total body surface area on clinical outcomes such as length of hospital stay, total fluid requirements, and mortality.
Study identification
- NCT ID
- NCT05612867
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2020
- Primary completion
- Jan 7, 2021
- Completion
- Jan 7, 2021
- Last update posted
- Nov 9, 2022
2020 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arrowhead Regional Medical Center | Colton | California | 92324 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Burns trials
Other public records listing Burns. Sorted by last update posted; newest first. Not a recommendation.
- NCT06503406: A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds Recruiting
- NCT06857448: Autologous Point-of-Care Adipose Therapy: Recent Injury Recruiting
- NCT06857435: Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar Recruiting
- NCT07656545: Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers Not yet recruiting
- NCT07494773: Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection Not yet recruiting
- NCT01297400: Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05612867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2022 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05612867 live on ClinicalTrials.gov.